Cleo Diagnostics Ltd has released a press release.
CLEO Raises $5m to Support U.S. Market Launch
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CLEO Diagnostics
- Trading Halt
- Cleo Strengthens Cash Position with $1.7m R&D Tax Refund
- CLEO Appoints First Key Opinion Leader to Support US Market
- CLEO Significantly Expands Addressable Market
- CLEO Successfully Completes Stage 1 MDSAP Audit
Later from CLEO Diagnostics
- Quarterly activities and cashflow report
- CLEO Confirms Next-Gen Platform for Ovarian Cancer Test
- Appendix 4D and Half Yearly Accounts
- CLEO Optimises Biomarker Panel Ahead of FDA Submission
- Sample Collection Completion for Pivotal US Clinical Trial
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics